IDO1 and breast cancer: In mouse models of breast cancer, IDO1 inhibition with 1-methyltryptophan had only limited therapeutic effects in monotherapy, but the antitumour activity of this compound was enhanced when it was given in combination with classical cytotoxic agents such as paclitaxel (Muller et al, 2005).